Principal Nate Manley was interviewed by Insights Bio this month for a Cell and Gene Therapy Insights raw and starting materials spotlight article entitled, "Emerging trends in control and regulation of immunotherapy cellular starting materials.
"Read the full article, including his answers to questions such as, "Are there any common pitfalls that you see cell and gene therapy developers and manufacturers falling into in terms of their cellular starting material testing?" (for free!) here: https://www.insights.bio/cell-and-gene-therapy-insights/journal/article/1978/Emerging-trends-in-control-and-regulation-of-immunotherapy-cellular-starting-materials
